Abstract
Electronic medical record platforms fail to support provider alerts when a drug is discontinued. Protease inhibitors, often boosted by ritonavir or cobicistat, increase the serum concentration of calcineurin inhibitors. This case demonstrates acute liver transplant rejection in an HIV-positive recipient due to a failure to recognize the loss of protease inhibitor interaction with his immunosuppressive regimen.
Author supplied keywords
Cite
CITATION STYLE
Hemmersbach-Miller, M., Berg, C. L., Messina, J. A., & Wolfe, C. R. (2018). Transplant drug interactions and a word of caution for the HIV provider. A case report. Open Forum Infectious Diseases, 5(4). https://doi.org/10.1093/ofid/ofy070
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.